Schreyer E, Obringer C, Messaddeq N, Kieffer B, et al. PATAS, a First-in-Class Therapeutic Peptide Biologic, Improves Whole-Body Insulin Resistance and Associated Comorbidities In Vivo. Diabetes 2022;71:2034-2047.
PMID: 35822820